LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 254 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 10.51 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $445,761 | -14.2% | 7,438 | +3.2% | 0.00% | 0.0% |
| Q2 2023 | $519,693 | +29.6% | 7,208 | +32.3% | 0.00% | 0.0% |
| Q1 2023 | $400,882 | +23.8% | 5,450 | +12.4% | 0.00% | 0.0% |
| Q4 2022 | $323,780 | -23.3% | 4,847 | -1.2% | 0.00% | 0.0% |
| Q3 2022 | $422,000 | +68.1% | 4,904 | +76.2% | 0.00% | 0.0% |
| Q2 2022 | $251,000 | -15.2% | 2,783 | +6.4% | 0.00% | 0.0% |
| Q1 2022 | $296,000 | -85.5% | 2,616 | -80.3% | 0.00% | -75.0% |
| Q4 2021 | $2,040,000 | -4.2% | 13,255 | -13.3% | 0.00% | 0.0% |
| Q3 2021 | $2,130,000 | +232.8% | 15,288 | +212.2% | 0.00% | +300.0% |
| Q2 2021 | $640,000 | -25.8% | 4,897 | -21.9% | 0.00% | -50.0% |
| Q1 2021 | $863,000 | -85.1% | 6,272 | -89.3% | 0.00% | -86.7% |
| Q4 2020 | $5,808,000 | +3.1% | 58,442 | -1.1% | 0.02% | -6.2% |
| Q3 2020 | $5,634,000 | +8.9% | 59,112 | +27.7% | 0.02% | 0.0% |
| Q2 2020 | $5,175,000 | +87.6% | 46,291 | +21.4% | 0.02% | +60.0% |
| Q1 2020 | $2,759,000 | +4.0% | 38,117 | +53.3% | 0.01% | +25.0% |
| Q4 2019 | $2,653,000 | -66.3% | 24,869 | -68.4% | 0.01% | -60.0% |
| Q3 2019 | $7,873,000 | +171.7% | 78,652 | +212.9% | 0.02% | +122.2% |
| Q2 2019 | $2,898,000 | +6.6% | 25,138 | +17.9% | 0.01% | 0.0% |
| Q1 2019 | $2,718,000 | -56.4% | 21,322 | -23.6% | 0.01% | -59.1% |
| Q4 2018 | $6,238,000 | +21.7% | 27,923 | +49.1% | 0.02% | +15.8% |
| Q3 2018 | $5,127,000 | -1.3% | 18,724 | -25.3% | 0.02% | +5.6% |
| Q2 2018 | $5,193,000 | +130.0% | 25,061 | +83.4% | 0.02% | +100.0% |
| Q1 2018 | $2,258,000 | +51.8% | 13,666 | +25.9% | 0.01% | +80.0% |
| Q4 2017 | $1,487,000 | +5.8% | 10,857 | +5.2% | 0.01% | 0.0% |
| Q3 2017 | $1,405,000 | -54.9% | 10,316 | -59.8% | 0.01% | -58.3% |
| Q2 2017 | $3,116,000 | +1005.0% | 25,669 | +862.1% | 0.01% | +1100.0% |
| Q1 2017 | $282,000 | -79.1% | 2,668 | -79.9% | 0.00% | -85.7% |
| Q4 2016 | $1,350,000 | +52.4% | 13,281 | +52.9% | 0.01% | +40.0% |
| Q3 2016 | $886,000 | -22.8% | 8,684 | -9.7% | 0.01% | -28.6% |
| Q2 2016 | $1,147,000 | +3.1% | 9,617 | -7.5% | 0.01% | 0.0% |
| Q1 2016 | $1,113,000 | -64.1% | 10,394 | -63.6% | 0.01% | -63.2% |
| Q4 2015 | $3,097,000 | +106.3% | 28,566 | +63.0% | 0.02% | +35.7% |
| Q3 2015 | $1,501,000 | +43.1% | 17,526 | +68.5% | 0.01% | +55.6% |
| Q2 2015 | $1,049,000 | +107.3% | 10,400 | +57.8% | 0.01% | +125.0% |
| Q1 2015 | $506,000 | – | 6,589 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $8,459 | 3.32% |
| VILLERE ST DENIS J & CO LLC | 480,807 | $35,368,162 | 2.57% |
| Chicago Capital, LLC | 449,508 | $33,065,822 | 1.64% |
| RICE HALL JAMES & ASSOCIATES, LLC | 288,345 | $21,210,681 | 1.20% |
| Smith, Graham & Co., Investment Advisors, LP | 65,163 | $4,793,390 | 0.58% |
| Stephens Investment Management Group LLC | 455,089 | $33,476,347 | 0.56% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 201,993 | $14,858,605 | 0.53% |
| WOODSTOCK CORP | 52,604 | $3,869,550 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,142,607 | 0.41% |
| Jackson Creek Investment Advisors LLC | 12,726 | $936 | 0.39% |